Tust Techasith

Tust Techasith practices at Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian.

Tust Techasith's NPI, 1851681308, was assigned on April 18, 2011. Tust Techasith graduated from Harvard Medical School in 2011. Tust Techasith holds California license A126248.

Tust Techasith's primary practice is Hoag Hospital Newport Beach, at One Hoag Drive, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 764-4624. Tust Techasith also practices at Hoag Hospital Newport Beach, 1 Hoag Dr, Newport Beach, CA 92663.

Tust Techasith's primary practice is Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian. Tust Techasith is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Tust Techasith to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tust Techasith practices, 4 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Tust Techasith's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Tust Techasith is licensed in California.

CMS data shows 1,568 Medicare services from Tust Techasith across 35 procedure codes in 2024, for 877 Medicare patients. Medicare paid $90,742 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 877 Medicare patients who saw Tust Techasith in 2024. The largest group is 75 to 84, with 371 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tust Techasith's median patient age at 70, with 50% women.

In 2024, Tust Techasith wrote 26 Medicare Part D claims for 21 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $100 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Tust Techasith for performance year 2024, reported as part of a group. Tust Techasith accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 179 general payments to Tust Techasith from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Penumbra, Inc. paid the most, $2,956.

Tust Techasith graduated from Harvard Medical School in 2011.